These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Lessons in détente or know thy host: the immunomodulatory gene products of myxoma virus. Zúñiga MC J Biosci; 2003 Apr; 28(3):273-85. PubMed ID: 12734406 [TBL] [Abstract][Full Text] [Related]
43. The viral ankyrin repeat protein (ORF124L) from infectious spleen and kidney necrosis virus attenuates nuclear factor-κB activation and interacts with IκB kinase β. Guo CJ; Chen WJ; Yuan LQ; Yang LS; Weng SP; Yu XQ; He JG J Gen Virol; 2011 Jul; 92(Pt 7):1561-1570. PubMed ID: 21471317 [TBL] [Abstract][Full Text] [Related]
44. SERP1, a serine proteinase inhibitor encoded by myxoma virus, is a secreted glycoprotein that interferes with inflammation. Macen JL; Upton C; Nation N; McFadden G Virology; 1993 Aug; 195(2):348-63. PubMed ID: 8337817 [TBL] [Abstract][Full Text] [Related]
45. Identification of host range mutants of myxoma virus with altered oncolytic potential in human glioma cells. Barrett JW; Alston LR; Wang F; Stanford MM; Gilbert PA; Gao X; Jimenez J; Villeneuve D; Forsyth P; McFadden G J Neurovirol; 2007 Dec; 13(6):549-60. PubMed ID: 18097886 [TBL] [Abstract][Full Text] [Related]
46. The complete DNA sequence of myxoma virus. Cameron C; Hota-Mitchell S; Chen L; Barrett J; Cao JX; Macaulay C; Willer D; Evans D; McFadden G Virology; 1999 Nov; 264(2):298-318. PubMed ID: 10562494 [TBL] [Abstract][Full Text] [Related]
47. Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor. Wang G; Barrett JW; Stanford M; Werden SJ; Johnston JB; Gao X; Sun M; Cheng JQ; McFadden G Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4640-5. PubMed ID: 16537421 [TBL] [Abstract][Full Text] [Related]
48. The α2,3-sialyltransferase encoded by myxoma virus is a virulence factor that contributes to immunosuppression. Boutard B; Vankerckhove S; Markine-Goriaynoff N; Sarlet M; Desmecht D; McFadden G; Vanderplasschen A; Gillet L PLoS One; 2015; 10(2):e0118806. PubMed ID: 25705900 [TBL] [Abstract][Full Text] [Related]
49. Serp2, an inhibitor of the interleukin-1beta-converting enzyme, is critical in the pathobiology of myxoma virus. Messud-Petit F; Gelfi J; Delverdier M; Amardeilh MF; Py R; Sutter G; Bertagnoli S J Virol; 1998 Oct; 72(10):7830-9. PubMed ID: 9733819 [TBL] [Abstract][Full Text] [Related]
50. Limitations of plasmid vaccines to complex viruses: selected myxoma virus antigens as DNA vaccines were not protective. Adams MM; van Leeuwen BH; Kerr PJ Vaccine; 2004 Nov; 23(2):198-204. PubMed ID: 15531037 [TBL] [Abstract][Full Text] [Related]
51. Poxvirus host range genes. Werden SJ; Rahman MM; McFadden G Adv Virus Res; 2008; 71():135-71. PubMed ID: 18585528 [TBL] [Abstract][Full Text] [Related]
52. SERP-1, a poxvirus-encoded serpin, is expressed as a secreted glycoprotein that inhibits the inflammatory response to myxoma virus infection. Nash P; Lucas A; McFadden G Adv Exp Med Biol; 1997; 425():195-205. PubMed ID: 9433502 [No Abstract] [Full Text] [Related]
53. Development and validation of a Myxoma virus real-time polymerase chain reaction assay. Albini S; Sigrist B; Güttinger R; Schelling C; Hoop RK; Vögtlin A J Vet Diagn Invest; 2012 Jan; 24(1):135-7. PubMed ID: 22362943 [TBL] [Abstract][Full Text] [Related]
54. The myxoma virus M-T4 gene encodes a novel RDEL-containing protein that is retained within the endoplasmic reticulum and is important for the productive infection of lymphocytes. Barry M; Hnatiuk S; Mossman K; Lee SF; Boshkov L; McFadden G Virology; 1997 Dec; 239(2):360-77. PubMed ID: 9434727 [TBL] [Abstract][Full Text] [Related]
55. Recombinant Myxoma Virus Expressing Walleye Dermal Sarcoma Virus orfC Is Attenuated in Rabbits. Ashton LV; Quackenbush SL; Castle J; Wilson G; McCoy J; Jordan M; MacNeill AL Viruses; 2020 May; 12(5):. PubMed ID: 32397134 [TBL] [Abstract][Full Text] [Related]
56. Reverse Engineering Field Isolates of Myxoma Virus Demonstrates that Some Gene Disruptions or Losses of Function Do Not Explain Virulence Changes Observed in the Field. Liu J; Cattadori IM; Sim DG; Eden JS; Holmes EC; Read AF; Kerr PJ J Virol; 2017 Oct; 91(20):. PubMed ID: 28768866 [TBL] [Abstract][Full Text] [Related]
57. Transforming growth factor alpha, Shope fibroma growth factor, and vaccinia growth factor can replace myxoma growth factor in the induction of myxomatosis in rabbits. Opgenorth A; Nation N; Graham K; McFadden G Virology; 1993 Feb; 192(2):701-9. PubMed ID: 8380671 [TBL] [Abstract][Full Text] [Related]
58. Inhibition of macrophage activation by the myxoma virus M141 protein (vCD200). Zhang L; Stanford M; Liu J; Barrett C; Jiang L; Barclay AN; McFadden G J Virol; 2009 Sep; 83(18):9602-7. PubMed ID: 19570854 [TBL] [Abstract][Full Text] [Related]
59. F-box-like domains are present in most poxvirus ankyrin repeat proteins. Mercer AA; Fleming SB; Ueda N Virus Genes; 2005 Oct; 31(2):127-33. PubMed ID: 16025237 [TBL] [Abstract][Full Text] [Related]
60. Role of the myxoma virus soluble CC-chemokine inhibitor glycoprotein, M-T1, during myxoma virus pathogenesis. Lalani AS; Masters J; Graham K; Liu L; Lucas A; McFadden G Virology; 1999 Apr; 256(2):233-45. PubMed ID: 10191189 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]